Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...

Neurochemical Transmission: Sites of Drug Action

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...

Role of Neurotransmitters in Memory

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The human claustrum supports cognitive networks for externally and internally driven task demands.

PLoS biology·2026

Same author

External Globus Pallidus Arkypallidal Circuit Dynamics Gate Risk-Taking Behavior.

bioRxiv : the preprint server for biology·2026

Same author

Anterior cingulate cortex activation of claustrum projection neuron subtypes is enhanced by alcohol.

Neuropharmacology·2026

Same author

Motor cortex somatostatin interneurons adaptively shape the structure of action sequences.

Nature communications·2026

Same author

Perineuronal Net and Inhibitory Synapse Remodeling on Striatal Fast-Spiking Interneurons by Chronic Alcohol Exposure.

Biological psychiatry·2026

Same author

SqueakPose Studio: An end-to-end platform for pose estimation and real-time edge-AI deployment.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

Endocannabinoid-dopamine interactions in striatal synaptic plasticity.

Brian N Mathur¹, David M Lovinger

¹Section on Synaptic Pharmacology, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health Rockville, MD, USA.

Frontiers in Pharmacology

|April 25, 2012

Summary

This summary is machine-generated.

The nigrostriatal dopaminergic system controls actions and learning. Dopamine D2 receptor signaling is key for regulating corticostriatal glutamate release via endocannabinoids, relevant to Parkinson's disease.

Keywords:

5-HT1b CB1 Parkinson’s disease adenosine long-term depression medium spiny neuron serotonin

More Related Videos

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine

Published on: April 23, 2020

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Related Experiment Videos

Last Updated: May 22, 2026

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine

Published on: April 23, 2020

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Area of Science:

Neuroscience
Cellular Signaling
Neuropharmacology

Background:

The nigrostriatal dopaminergic system plays a crucial role in motor control and learning.
Corticostriatal synapses are the primary synapses in the striatum and are modulated by this system.
Dopamine D2 receptor signaling is essential for regulating neurotransmitter release at these synapses.

Purpose of the Study:

To review the mechanism of D2 dopamine receptor signaling in endocannabinoid-mediated depression of corticostriatal glutamate release.
To discuss novel signaling pathways that interact with this system.
To highlight the relevance of these mechanisms to Parkinson's disease.

Main Methods:

Literature review of existing research on the nigrostriatal dopaminergic system.
Analysis of signaling pathways involved in corticostriatal modulation.
Integration of recent findings on endocannabinoid system changes in Parkinson's disease patients.

Main Results:

Dopamine D2 receptor signaling is necessary for endocannabinoid-mediated inhibition of glutamate release.
Newly identified pathways dynamically control cortical input to the striatum.
The striatal endocannabinoid system shows alterations in Parkinson's disease.

Conclusions:

The nigrostriatal pathway's modulation of corticostriatal synapses is complex and involves D2 receptor and endocannabinoid signaling.
Understanding these pathways offers insights into action control and learning.
Dysregulation of this system may contribute to Parkinson's disease pathogenesis.